BO4 Stock Overview
Engages in the development, production, and marketing of specialized biomaterials and biochemicals in Norway, rest of Europe, the United States, Asia, and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 3/6 |
| Past Performance | 2/6 |
| Financial Health | 6/6 |
| Dividends | 5/6 |
Rewards
Risk Analysis
No risks detected for BO4 from our risk checks.
Borregaard ASA Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | NOK 15.50 |
| 52 Week High | NOK 17.54 |
| 52 Week Low | NOK 13.36 |
| Beta | 0.51 |
| 11 Month Change | -9.88% |
| 3 Month Change | -2.76% |
| 1 Year Change | 9.62% |
| 33 Year Change | -29.22% |
| 5 Year Change | 64.37% |
| Change since IPO | 82.96% |
Recent News & Updates
Recent updates
Shareholder Returns
| BO4 | DE Chemicals | DE Market | |
|---|---|---|---|
| 7D | 0.9% | -1.3% | -1.3% |
| 1Y | 9.6% | -1.6% | 7.4% |
Return vs Industry: BO4 exceeded the German Chemicals industry which returned -1.2% over the past year.
Return vs Market: BO4 exceeded the German Market which returned 7.1% over the past year.
Price Volatility
| BO4 volatility | |
|---|---|
| BO4 Average Weekly Movement | 4.1% |
| Chemicals Industry Average Movement | 4.2% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 10.8% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: BO4 has not had significant price volatility in the past 3 months compared to the German market.
Volatility Over Time: BO4's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2012 | 1,127 | Per Sørlie | www.borregaard.com |
Borregaard ASA engages in the development, production, and marketing of specialized biomaterials and biochemicals in Norway, rest of Europe, the United States, Asia, and internationally. It operates in three segments: BioSolutions, BioMaterials, and Fine Chemicals. The BioSolutions segment develops, produces, and sells biopolymers for various applications, such as agrochemicals, batteries, industrial binders, and construction; and biovanillin for flavor and fragrance companies, as well as for food and beverage industry.
Borregaard ASA Fundamentals Summary
| BO4 fundamental statistics | |
|---|---|
| Market cap | €1.57b |
| Earnings (TTM) | €70.08m |
| Revenue (TTM) | €644.62m |
22.4x
P/E Ratio2.4x
P/S RatioIs BO4 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| BO4 income statement (TTM) | |
|---|---|
| Revenue | NOK 7.48b |
| Cost of Revenue | NOK 2.87b |
| Gross Profit | NOK 4.61b |
| Other Expenses | NOK 3.80b |
| Earnings | NOK 813.00m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
Jan 29, 2025
| Earnings per share (EPS) | 8.15 |
| Gross Margin | 61.63% |
| Net Profit Margin | 10.87% |
| Debt/Equity Ratio | 33.5% |
How did BO4 perform over the long term?
See historical performance and comparison